Ofer Ben-Izhak
Overview
Explore the profile of Ofer Ben-Izhak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
899
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Agaimy A, Naroditsky I, Ben-Izhak O
Ann Diagn Pathol
. 2021 Jun;
53:151759.
PMID: 34111706
Primary myoepithelial carcinoma of the lung is exceptionally rare and, hence, remained poorly characterized. We present 3 tumors affecting 2 males and 1 female aged 60 to 84 years. Tumor...
2.
Butbul Aviel Y, Ofir A, Ben-Izhak O, Vlodavsky E, Karbian N, Brik R, et al.
Rheumatology (Oxford)
. 2021 Jan;
60(10):4888-4898.
PMID: 33493343
Objective: To investigate phenotypic and molecular characteristics of a consanguineous family with autosomal-recessive, polyarticular, juvenile isiopathic arthriris (JIA) with extra-articular manifestations, including renal amyloidosis and Crohn's disease, associated with a...
3.
Grad-Akrish S, Rachmiel A, Ben-Izhak O
Oral Surg Oral Med Oral Pathol Oral Radiol
. 2020 Dec;
131(5):572-581.
PMID: 33309262
Objective: Special AT-rich binding protein 2 (SATB2) is an immunohistochemical marker for osteoblast differentiation. Our aim was to investigate SATB2 expression in oral osteosarcoma and other bone-producing oral tumors/reactive lesions...
4.
Akrish S, Eskander-Hashoul L, Rachmiel A, Ben-Izhak O
Pathol Res Pract
. 2019 Oct;
215(12):152670.
PMID: 31630872
Objective: Proliferative verrucous leukoplakia is classified as a potentially malignant disorder because of its high rate of malignant transformation. PVL progresses in a series of clinical stages where the early...
5.
Hochwald O, Gil Z, Gordin A, Winer Z, Avrahami R, Abargel E, et al.
J Med Case Rep
. 2019 Mar;
13(1):73.
PMID: 30851737
Background: A giant congenital cervical teratoma is often highly vascularized; thus, in addition to a life-threatening airway occlusion at birth it comprises a high risk for significant and lethal blood...
6.
Dahan I, Thawho N, Farber E, Nakhoul N, Asleh R, Levy A, et al.
J Diabetes Res
. 2018 Sep;
2018:7163652.
PMID: 30250850
The haptoglobin (Hp) genotype (1-1 and 2-2) is a major determinant of nephropathy progression in diabetes mellitus patients. Hp 2-2 diabetic mice have impaired Hb clearance and increased iron deposits...
7.
Akrish S, Rachmiel A, Abu El-Naaj I, Ben-Izhak O
Oral Surg Oral Med Oral Pathol Oral Radiol
. 2018 Aug;
129(1):3-7.
PMID: 30150121
No abstract available.
8.
Fahoum I, Forer R, Volodarsky D, Vulih I, Bick T, Sarji S, et al.
Technol Cancer Res Treat
. 2018 Aug;
17:1533033818793653.
PMID: 30099961
Objective: Circulating tumor DNA is a promising noninvasive tool for cancer monitoring. One of the challenges in applying this tool is the detection of low-frequency mutations. The detection limit of...
9.
Perets R, Greenberg O, Shentzer T, Semenisty V, Epelbaum R, Bick T, et al.
Oncologist
. 2018 Jan;
23(5):566-572.
PMID: 29371474
Background: Many new pancreatic cancer treatment combinations have been discovered in recent years, yet the prognosis of pancreatic ductal adenocarcinoma (PDAC) remains grim. The advent of new treatments highlights the...
10.
Dias-Polak D, Geffen Y, Ben-Izhak O, Bergman R
Am J Dermatopathol
. 2017 Dec;
39(12):890-895.
PMID: 29190217
Background: Histopathology plays an important role in the diagnosis of cutaneous leishmaniasis (CL) but Leishman-Donovan (LD) bodies may not always be discernible. Recently, anti-CD1a antibody (Ab), clone MTB1, was found...